Chebel Khalil, MD
Nephrology · Cincinnati, OHNPI 1841400645
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,975 of the $71,778 with a category attached, or 66.8%. Amgen accounts for 65.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $40,270, more than ten times the $90 reported in 2019. Among nephrology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 223 payments — averaging $321.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$47K
- Travere Therapeutics, Inc.$22K
- Merit Medical Systems Inc$778
- AstraZeneca$615
- Boehringer Ingelheim$421
- Calliditas Therapeutics US Inc.$169
- plus $736 from 13 others
What the payments were for
- Consulting fees$12,70018%
- Speaking & faculty fees$47,97567%
- Travel & lodging$5,0447%
- Food & beverage$5,8948%
- Education$1650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 85 | $47,086 |
| Travere Therapeutics, Inc. | 50 | $21,973 |
| Merit Medical Systems Inc | 4 | $778 |
| AstraZeneca(2 entities) | 24 | $615 |
| Boehringer Ingelheim | 22 | $421 |
| Calliditas Therapeutics US Inc. | 8 | $169 |
| Bard Peripheral Vascular, Inc. | 2 | $157 |
| Bayer | 7 | $152 |
| Novartis | 4 | $101 |
| Vifor Pharma, Inc. | 5 | $98 |
| Ardelyx, Inc. | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 3 | $39 |
| Baxter Healthcare | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Fresenius USA Marketing, Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Covidien LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$45,783
- Filspari$18,399
- Peritoneal Dialysis Systems$671
How this compares
$71,778 in reported general payments places this provider in the 95th percentile of 450 nephrology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $12,502 |
| Sevelamer Carbonate | 34 | $5,425 |
| Nifedipine ErNifedipine | 135 | $4,364 |
| Calcitriol | 288 | $3,466 |
| Calcium Acetate | 25 | $2,357 |
| Clonidine | 21 | $2,085 |
| Torsemide | 60 | $1,633 |
| Doxazosin Mesylate | 67 | $1,223 |
| Allopurinol | 149 | $1,200 |
| Hydralazine Hcl | 73 | $1,098 |
| Potassium Citrate ErPotassium Citrate | 11 | $976 |
| Metoprolol Succinate | 51 | $813 |
| Losartan Potassium | 82 | $674 |
| Valsartan | 20 | $668 |
| Metoprolol Tartrate | 120 | $637 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Cincinnati
- Amit GovilCincinnati$298K
- Prabir Roy ChaudhuryCincinnati$205K
- Charuhas ThakarCincinnati$107K
- Arshdeep TindniCincinnati$41K
- Joseph KremerCincinnati$29K
- Tahir SajjadCincinnati$20K
- Silvi ShahCincinnati$14K
- Prakash GudsoorkarCincinnati$10K
- Ahmad AnjakCincinnati$9K
- Karl PembaurCincinnati$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.